These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8480740)

  • 1. Biochemical and clinical effects of aspartame in patients with chronic, stable alcoholic liver disease.
    Hertelendy ZI; Mendenhall CL; Rouster SD; Marshall L; Weesner R
    Am J Gastroenterol; 1993 May; 88(5):737-43. PubMed ID: 8480740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of repeated ingestion of aspartame-sweetened beverage on plasma amino acid, blood methanol, and blood formate concentrations in normal adults.
    Stegink LD; Filer LJ; Bell EF; Ziegler EE; Tephly TR
    Metabolism; 1989 Apr; 38(4):357-63. PubMed ID: 2566887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct and indirect cellular effects of aspartame on the brain.
    Humphries P; Pretorius E; Naudé H
    Eur J Clin Nutr; 2008 Apr; 62(4):451-62. PubMed ID: 17684524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma and erythrocyte concentrations of free amino acids in adult humans administered abuse doses of aspartame.
    Stegink LD; Filer LJ; Baker GL
    J Toxicol Environ Health; 1981 Feb; 7(2):291-305. PubMed ID: 7230277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of aspartame in pregnancy.
    Sturtevant FM
    Int J Fertil; 1985; 30(1):85-7. PubMed ID: 2862125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of aspartame by apparently healthy children and adolescents.
    Frey GH
    J Toxicol Environ Health; 1976 Nov; 2(2):401-15. PubMed ID: 137987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies.
    Magnuson BA; Burdock GA; Doull J; Kroes RM; Marsh GM; Pariza MW; Spencer PS; Waddell WJ; Walker R; Williams GM
    Crit Rev Toxicol; 2007; 37(8):629-727. PubMed ID: 17828671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of aspartame and aspartate loading upon plasma and erythrocyte free amino acid levels in normal adult volunteers.
    Stegink LD; Filer LJ; Baker GL
    J Nutr; 1977 Oct; 107(10):1837-45. PubMed ID: 903828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of aspartame and phenylalanine on meal-time food intake of humans.
    Anderson GH; Leiter LA
    Appetite; 1988; 11 Suppl 1():48-53. PubMed ID: 3056266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological properties of aspartame. I. Evaluation of central nervous system effects.
    Potts WJ; Bloss JL; Nutting EF
    J Environ Pathol Toxicol; 1980; 3(5-6):341-53. PubMed ID: 7441089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of aspartame loading on plasma and erythrocyte free amino acid concentrations in one-year-old infants.
    Filer LJ; Baker GL; Stegink LD
    J Nutr; 1983 Aug; 113(8):1591-9. PubMed ID: 6135765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of aspartame on plasma amino acid profiles of diabetic patients with chronic renal failure.
    Gupta V; Cochran C; Parker TF; Long DL; Ashby J; Gorman MA; Liepa GU
    Am J Clin Nutr; 1989 Jun; 49(6):1302-6. PubMed ID: 2729170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological and biochemical investigations in heterozygotes for phenylketonuria during ingestion of high dose aspartame (a sweetener containing phenylalanine).
    Trefz F; de Sonneville L; Matthis P; Benninger C; Lanz-Englert B; Bickel H
    Hum Genet; 1994 Apr; 93(4):369-74. PubMed ID: 8168806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of aspartame and glucose administration on brain and plasma levels of large neutral amino acids and brain 5-hydroxyindoles.
    Yokogoshi H; Roberts CH; Caballero B; Wurtman RJ
    Am J Clin Nutr; 1984 Jul; 40(1):1-7. PubMed ID: 6204522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of aspartame and its L-phenylalanine methyl ester decomposition product by the porcine gut.
    Burgert SL; Andersen DW; Stegink LD; Takeuchi H; Schedl HP
    Metabolism; 1991 Jun; 40(6):612-8. PubMed ID: 1865825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated ingestion of aspartame-sweetened beverages: further observations in individuals heterozygous for phenylketonuria.
    Stegink LD; Filer LJ; Bell EF; Ziegler EE; Tephly TR; Krause WL
    Metabolism; 1990 Oct; 39(10):1076-81. PubMed ID: 2215254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspartame administration to the infant monkey: hypothalamic morphology and plasma amino acid levels.
    Reynolds WA; Stegink LD; Filer LJ; Renn E
    Anat Rec; 1980 Sep; 198(1):73-85. PubMed ID: 7457932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma concentrations and pharmacokinetics of phenylalanine in rats and mice administered aspartame.
    Hjelle JJ; Dudley RE; Marietta MP; Sanders PG; Dickie BC; Brisson J; Kotsonis FN
    Pharmacology; 1992; 44(1):48-60. PubMed ID: 1553388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspartame and phenylalanine do not enhance theophylline-induced seizures in rats.
    Zhi JQ; Levy G
    Res Commun Chem Pathol Pharmacol; 1989 Oct; 66(1):171-4. PubMed ID: 2616898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative metabolism of aspartame in experimental animals and humans.
    Ranney RE; Oppermann JA; Muldoon E; McMahon FG
    J Toxicol Environ Health; 1976 Nov; 2(2):441-51. PubMed ID: 827618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.